Quadrant Capital Group’s NRC Health Common Stock NRC Stock Holding History

Quadrant Capital Group’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,204	Closed	-$37.4K	–	2109
2026 Q1	$37.4K	Sell	2,204 -379	-15%	-$6.44K	﹤0.01%	1795
2025 Q4	$48.5K	Buy	2,583 +1,962	+316%	+$29.6K	﹤0.01%	1693
2025 Q3	$7.94K	Buy	+621	New	+$9.31K	﹤0.01%	2223
2025 Q2	–	Sell	-4,367	Closed	-$55.9K	–	2157
2025 Q1	$55.9K	Sell	4,367 -639	-13%	-$10.3K	﹤0.01%	1675
2024 Q4	$88.3K	Buy	5,006 +3,438	+219%	+$65.2K	0.01%	1110
2024 Q3	$35.8K	Buy	1,568 +879	+128%	+$19.9K	﹤0.01%	1626
2024 Q2	$15.8K	Buy	+689	New	+$21.2K	﹤0.01%	1957
2022 Q2	–	Sell	-104	Closed	-$4K	–	2670
2022 Q1	$4K	Buy	+104	New	+$4.07K	﹤0.01%	1983
2021 Q3	–	Sell	-4	Closed	–	–	2603
2021 Q2	$0	Buy	+4	New	+$190	﹤0.01%	2505
2021 Q1	–	Sell	-11	Closed	–	–	2432
2020 Q4	$0	Buy	+11	New	+$565	﹤0.01%	2352

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

FMII

Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Quadrant Capital Group's NRC Position: Q2 2026 in Review

Quadrant Capital Group sold out of NRC Health Common Stock (NRC) in Q2 2026, closing a stake of 2,204 shares — an estimated $37.4K sold.

Quadrant Capital Group first reported a position in NRC in Q4 2020 and held it in 10 quarters. The position peaked at $88.3K in Q4 2024. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

Quadrant Capital Group reported no remaining NRC Health Common Stock position as of Q2 2026 after selling out during the quarter.
Quadrant Capital Group sold 2,204 NRC Health Common Stock shares in Q2 2026, an estimated $37.4K.
Quadrant Capital Group first reported a position in NRC Health Common Stock in Q4 2020 and held it in 10 quarters.
Quadrant Capital Group's NRC Health Common Stock position peaked at $88.3K in Q4 2024.
124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.